Drug
AMXT-1501 clinical trials
Also written AMXT1501.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2018 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Aminex Therapeutics, Inc. (3)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses AMXT-1501 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Oral AMXT 1501 Dicaprate in Combination With IV DFMOTerminatedPhase 1/2Aminex Therapeutics, Inc.NCT05500508Written as AMXT1501
- Oral AMXT 1501 Dicaprate in Combination With DFMOCompletedPhase 1Aminex Therapeutics, Inc.NCT03536728Written as AMXT1501
- Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy VolunteersWithdrawnPhase 1Aminex Therapeutics, Inc.NCT03077477Written as AMXT 1501